0.8817
price down icon4.98%   -0.0462
after-market Handel nachbörslich: .90 0.0183 +2.08%
loading

Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
6.22%
40.59
38.21 37.20 38.90 40.78
Cost Of Revenue
6.67%
11.12
11.91 9.857 8.457 10.23
Gross Profit
12.05%
29.47
26.30 27.34 30.45 30.55
Operating Expenses
3.16%
29.43
30.39 28.98 27.29 26.38
Benefits Costs and Expenses
43.27%
43.54
30.39 28.98 27.29 26.38
Costs And Expenses
3.16%
29.43
30.39 28.98 27.29 26.38
Operating Income/Loss
100.93%
0.038
-4.093 -1.637 3.154 4.173
Income/Loss From Continuing Operations Before Tax
137.77%
-2.954
7.821 -2.381 2.635 14.40
Income/Loss From Continuing Operations After Tax
83.12%
-2.954
-17.50 -2.381 2.635 3.663
Net Income/Loss
83.12%
-2.954
-17.50 -2.381 2.635 3.663
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.78%
7.183
170.35 154.02 153.49 0.236
Diluted Average Shares
95.78%
7.183
170.35 154.02 196.92 0.236
Basic Earnings Per Share
90.00%
-0.010
-0.10 -0.02 0.02 0.02
Diluted Earnings Per Share
90.00%
-0.010
-0.10 -0.02 0.01 0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):